Authorities believe James had been poisoning his wife's drinks for several weeks before her death by using the chemicals he ...

The U.S. Food and Drug Administration and the U.S. Department of Agriculture  have announced a joint request for Information (RFI) about food date ...

The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease, ...

Merck’s new pulmonary arterial hypertension (PAH) medication has posted another batch of promising clinical trial data, bolstering the company’s case that its first-in-class therapy ought to become a ...

The recalled products were sold at Sprouts stores in multiple states, including Arizona, California, Texas, Pennsylvania, and ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Shares of Agios Pharmaceuticals AGIO lost 21% yesterday after management revealed that two thalassemia patients who received ...

A recent study has found that semaglutide reduced heart muscle mass in both lean and obese mice, as well as in lab-grown ...

The FDA and USDA seek industry and consumer input on food date labeling terms like Sell By, contributing to 20% of food waste ...

Atkinson Milling Company is recalling a variety of Hushpuppies due to an undeclared milk allergen. People who have an allergy ...

NewAmsterdam is singing data from its Broadway heart disease trial, hailing another phase 3 win for its cholesterol-busting ...

In the RewinD-LB Phase 2b trial, neflamapimod demonstrated a favorable safety and tolerability profile that is consistent with prior clinical studies, with no new safety signal identified.